The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 26, 2019
Filed:
Apr. 26, 2017
Applicant:
Oryzon Genomics S.a., Cornella de Llobregat, Barcelona, ES;
Inventors:
Alberto Ortega Muñoz, Barcelona, ES;
Matthew Colin Thor Fyfe, Chipping Norton, GB;
Marc Martinell Pedemonte, Barcelona, ES;
Maria de los Àngeles Estiarte Martinez, San Francisco, CA (US);
Nuria Valls Vidal, Barcelona, ES;
Guido Kurz, Barcelona, ES;
Julio Cesar Castro Palomino Laria, Barcelona, ES;
Assignee:
Oryzon Genomics S.A., Madrid, ES;
Primary Examiner:
Int. Cl.
CPC ...
C07C 211/36 (2006.01); C07D 213/74 (2006.01); C07C 271/24 (2006.01); C07C 275/26 (2006.01); C07D 231/12 (2006.01); C07D 207/14 (2006.01); C07D 277/28 (2006.01); C07D 295/096 (2006.01); C07D 295/135 (2006.01); C07D 295/26 (2006.01); C07D 213/30 (2006.01); C07D 213/38 (2006.01); C07D 307/52 (2006.01); C07C 311/08 (2006.01); C07C 311/21 (2006.01); C07C 215/46 (2006.01); C07C 217/54 (2006.01); C07C 209/28 (2006.01); C07C 211/38 (2006.01); C07C 269/00 (2006.01); C07C 273/18 (2006.01); C07C 211/40 (2006.01); C07C 213/00 (2006.01); C07C 215/64 (2006.01); C07C 217/74 (2006.01); C07C 273/00 (2006.01); C07D 213/57 (2006.01); C07D 213/73 (2006.01); C07D 231/56 (2006.01); C07D 333/20 (2006.01);
U.S. Cl.
CPC ...
C07C 211/36 (2013.01); C07C 209/28 (2013.01); C07C 211/38 (2013.01); C07C 211/40 (2013.01); C07C 213/00 (2013.01); C07C 215/46 (2013.01); C07C 215/64 (2013.01); C07C 217/54 (2013.01); C07C 217/74 (2013.01); C07C 269/00 (2013.01); C07C 271/24 (2013.01); C07C 273/00 (2013.01); C07C 273/18 (2013.01); C07C 275/26 (2013.01); C07C 311/08 (2013.01); C07C 311/21 (2013.01); C07D 207/14 (2013.01); C07D 213/30 (2013.01); C07D 213/38 (2013.01); C07D 213/57 (2013.01); C07D 213/73 (2013.01); C07D 213/74 (2013.01); C07D 231/12 (2013.01); C07D 231/56 (2013.01); C07D 277/28 (2013.01); C07D 295/096 (2013.01); C07D 295/135 (2013.01); C07D 295/26 (2013.01); C07D 307/52 (2013.01); C07D 333/20 (2013.01); C07B 2200/07 (2013.01); C07C 2601/02 (2017.05); C07C 2601/04 (2017.05); C07C 2601/14 (2017.05); C07C 2602/08 (2017.05);
Abstract
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.